Voir la version française Paris, March 13, 2025 – ONCOVITA, a biotechnology company specializing in innovative vaccine development and a spin-off from the Institut Pasteur, and UNITHER Pharmaceuticals, a global leader in sterile unit-dose manufacturing, announce a strategic partnership to develop and produce a new combined prophylactic vaccine for the prevention
Voir la version française Paris, France, Jan 24, 2025 – The Paris Saclay Cancer Cluster (PSCC) is proud to announce the selection of three new innovative oncology projects, bringing the total number of supported projects to 61. These bold and visionary initiatives exploit cutting-edge technologies to tackle the most complex challenges in cancer care.
Paris, 13 mars 2025 – ONCOVITA, société de biotechnologie spécialisée dans le développement de vaccins innovants, spin off de l’Institut Pasteur, et UNITHER Pharmaceuticals, leader mondial dans la fabrication d’unidoses stériles, annoncent leur partenariat stratégique pour le développement et la production d’un nouveau vaccin combiné prophylactique